Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Pregnancy can make you feel emotional, and your mood may change every moment. You can never anticipate how you may feel the next day. It happens because of your hormones. However, one of the hormones ...

To analyze the clinical characteristics, diagnostic challenges, treatment strategies, and long-term outcomes of ovarian ...

New research reveals that intermittent fasting can significantly enhance the effectiveness of oestrogen-blocking breast cancer therapies like tamoxifen. Studies show fasting triggers hormonal and ...

Estrogen and progesterone are complementary reproductive hormones. Estrogen shapes everything from puberty to menstrual cycles to bone health, and progesterone is key to the second half of the ...

Women who take progesterone in the year before becoming pregnant may reduce their risk for miscarriage by as much as 18%, according to a new study analyzing tens of thousands of pregnancies nationwide ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...

ER+/PR+ breast cancer is a subtype of ER positive breast cancer where the tumor cells express both estrogen receptors (ER) and progesterone receptors (PR) on the surface. As the most common type of ...